Skip to content

geroFarma

Active
Private limited companyfounded 2021active for 5 yearsAlbrecht Rodenbachlaan(Heu) 82, 8501 Kortrijk, BelgiumKBO/BCE: BE 0774.941.908
Summary

geroFarma has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €240,699 and a net result of €107,225. Equity is growing by about 67% per year across the filed financial years. Its solvency ranks better than 34% of 12,578 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€1.1mtotal assets 2025
Equity
€240,699
Profit
€107,225
Turnover not published (abbreviated format)
Financial health
85 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.4%
Structure
Holdings
2
Accounts 20 days early0 of 3 deeds read
Why 85raises riskFounded in 2021Sector: Retail trade (NACE 47)lowers riskSize: total assets €1.1mFigures for financial year 2025 (filed 11-07-2026)Show the evidence

Checked score

Score 2025
85 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 66% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 48+9
equity 22.9% of total assets
Liquidity 55+4
short-term debt 9.4% · cash 4.0%
Profitability 81+10
return on assets 10.2%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,230 companies, NACE 47, micro)
Last 24 months 11-2024: 6.1%highest value 12-2024: 2.0%▼ -4.1 percentage points vs 11-2024 01-2025: 2.0%● unchanged vs 12-2024 02-2025: 2.1%▲ +0.1 percentage points vs 01-2025 03-2025: 2.1%● unchanged vs 02-2025 04-2025: 2.5%▲ +0.4 percentage points vs 03-2025 05-2025: 3.3%▲ +0.8 percentage points vs 04-2025 06-2025: 3.3%● unchanged vs 05-2025 07-2025: 3.4%▲ +0.1 percentage points vs 06-2025 08-2025: 1.4%▼ -2.0 percentage points vs 07-2025 09-2025: 1.4%● unchanged vs 08-2025 10-2025: 1.3%▼ -0.1 percentage points vs 09-2025 11-2025: 1.3%● unchanged vs 10-2025 12-2025: 1.3%● unchanged vs 11-2025 01-2026: 1.3%● unchanged vs 12-2025 02-2026: 0.7%▼ -0.6 percentage points vs 01-2026 03-2026: 0.7%● unchanged vs 02-2026 04-2026: 0.8%▲ +0.1 percentage points vs 03-2026 05-2026: 0.9%▲ +0.1 percentage points vs 04-2026 06-2026: 1.0%▲ +0.1 percentage points vs 05-2026 07-2026: 1.2%▲ +0.2 percentage points vs 06-2026 08-2026: 0.5%▼ -0.7 percentage points vs 07-2026 09-2026: 0.4%▼ -0.1 percentage points vs 08-2026lowest value 10-2026: 0.4%● unchanged vs 09-2026lowest value
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.78, compared with 1.06 in 2024, above the usual 1.5; short-term debt: 9.4% and cash: 4% of total assets), but 77.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 39% on solvency, 61% on liquidity, 74% on profitability and 91% on growth.

The bankruptcy probability was computed on 20-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €1.1m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 11-07-2026)
NBB · annual accounts
raises risk · Founded in 2021
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-07-2026, 20 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
20 days early
2024
20 days early
2023
14 days early
2022
7 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 15 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 15 July (4 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
21-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Highest result from 2022 to 2025net €107,225 ▲98.5%
  3. Equity above €200,000equity €240,699 ▲80.3%

Financials · financial year 2025, abbreviated format

Equity
€240,699▲ 80.3%
2024 · €133,474
Total assets
€1.1m▲ 8.1%
2024 · €974,039
Net result
€107,225▲ 98.5%
2024 · €54,029
Working capital
€77,695▲ 1,485%
2024 · €4,902
Trend over the years

2022 to 2025, 4 financial years

The operating result has risen three years in a row; 2025 is 81% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€0.2m 2025 Net result€0.1m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2022202320242025
Operating result€0.02m-€0.04m▲ 132%€0.1m▲ 125%€0.2m▲ 81.0%
Net result€0.01mwithin the sector's middle half-€0.07mwithin the sector's middle half▲ 440%€0.05mwithin the sector's middle half▼ 18.4%€0.1mabove the sector's middle half▲ 98.5%
Equity€0.01mbelow the sector's middle half-€0.08mbelow the sector's middle half▲ 499%€0.1mwithin the sector's middle half▲ 68.0%€0.2mwithin the sector's middle half▲ 80.3%
Total assets€0.8mwithin the sector's middle half-€1.0mwithin the sector's middle half▲ 18.3%€1.0mwithin the sector's middle half▲ 1.1%€1.1mwithin the sector's middle half▲ 8.1%
Debt€0.8m-€0.9m▲ 10.3%€0.8m▼ 4.9%€0.8m▼ 3.3%
Working capital-€0.1mbelow the sector's middle half-€0.001mbelow the sector's middle half€0.005mbelow the sector's middle half▲ 599%€0.08mwithin the sector's middle half▲ 1,485%
Solvency1.6%below the sector's middle half-8.2%below the sector's middle half▲ 6.6pp13.7%below the sector's middle half▲ 5.5pp22.9%within the sector's middle half▲ 9.2pp
Current ratio0.17below the sector's middle half-1.01below the sector's middle half▲ 0.841.06within the sector's middle half▲ 0.051.78within the sector's middle half▲ 0.72
Return on assets (ROA)1.5%within the sector's middle half-6.9%within the sector's middle half▲ 5.4pp5.5%within the sector's middle half▼ 1.3pp10.2%within the sector's middle half▲ 4.6pp
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.1m
Fixed assets €876,187 ▼ 1.0%
Current assets €176,981 ▲ 99.4%
Equity and liabilities €1.1m
Equity €240,699 ▲ 80.3%
Debt €812,469 ▼ 3.3%
Debt's share of the balance-sheet total falls from 86.3% to 77.1%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€183,683▲
2024 · €104,734
Cash flow
€116,927▲
2024 · €62,643
Debt to equity
3.38▼
2024 · 6.30
ROE
44.5%▲
2024 · 40.5%
Interest coverage
9.72▲
2024 · 5.39
Debt ≤ 1 year
€99,285▲
2024 · €83,849
Debt > 1 year
€700,800▼
2024 · €751,650
Income taxes
€51,873▲
2024 · €25,614
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.0m€1.1m▲
Fixed assets21/28€0.9m€0.9m▼
Tangible fixed assets22/27€0.04m€0.03m▼
Furniture and vehicles24€0.04m€0.03m▼
Financial fixed assets28€0.8m€0.8m=
Current assets29/58€0.09m€0.2m▲
Amounts receivable within one year40/41€0.07m€0.1m▲
Trade receivables40€0€0.01m▲
Other amounts receivable41€0.07m€0.1m▲
Cash at bank and in hand54/58€0.01m€0.04m▲
Deferred charges and accrued income490/1€0.003m€0.001m▼
Equity and liabilities
Total equity and liabilities10/49€1.0m€1.1m▲
Equity10/15€0.1m€0.2m▲
Contributions10/11€0.001m€0.001m=
Reserves13€0.1m€0.2m▲
Distributable reserves133€0.1m€0.2m▲
Amounts payable17/49€0.8m€0.8m▼
Amounts payable after more than one year17€0.8m€0.7m▼
Financial debts170/4€0.8m€0.7m▼
Amounts payable within one year42/48€0.08m€0.1m▲
Current portion of amounts payable after more than one year42€0.05m€0.05m=
Trade debts44€0-
Suppliers440/4€0-
Taxes, remuneration and social security45€0.02m€0.05m▲
Taxes450/3€0.02m€0.05m▲
Remuneration and social security454/9€0.001m€0.001m=
Other amounts payable47/48€0.01m€284▼
Accrued charges and deferred income492/3€0.005m€0.01m▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.009m€0.01m▲
Other operating charges640/8€0.001m€0.002m▲
Gross operating margin9900€0.1m€0.2m▲
Operating profit (loss)9901€0.1m€0.2m▲
Financial income75/76B€0.003m€0.004m▲
Recurring financial income75€0.003m€0.004m▲
Financial charges65/66B€0.02m€0.02m▼
Recurring financial charges65€0.02m€0.02m▼
Profit (loss) for the period before taxes9903€0.08m€0.2m▲
Income taxes67/77€0.03m€0.05m▲
Profit (loss) for the period9904€0.05m€0.1m▲
Profit (loss) for the period to be appropriated9905€0.05m€0.1m▲
Appropriation of the result
Profit (loss) to be appropriated9906€0.05m€0.1m▲
Transfer to equity691/2€0.05m€0.1m▲
To other reserves6921€0.05m€0.1m▲

The notes to these accounts (18 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€788€0€8,615€9,702▲ 12.6%
Other operating charges640/8€295€771€749€1,513▲ 102%
Gross operating margin9900€19,492€43,427€105,483€185,196▲ 75.6%
Operating profit (loss)9901€18,409€42,656€96,119€173,980▲ 81.0%
Financial income75/76B-€50,000€2,955€4,006▲ 35.6%
Recurring financial income75-€50,000€2,955€4,006▲ 35.6%
Financial charges65/66B€49€11,400€19,431€18,889▼ 2.8%
Recurring financial charges65€49€11,400€19,431€18,889▼ 2.8%
Profit (loss) for the period before taxes9903€18,360€81,256€79,643€159,098▲ 99.8%
Income taxes67/77€6,103€15,068€25,614€51,873▲ 103%
Profit (loss) for the period9904€12,257€66,188€54,029€107,225▲ 98.5%
Profit (loss) for the period to be appropriated9905€12,257€66,188€54,029€107,225▲ 98.5%
Line2022202320242025Change
Assets
Total assets20/58€0.8m€1.0m€1.0m€1.1m▲ 8.1%
Fixed assets21/28€0.8m€0.8m€0.9m€0.9m▼ 1.0%
Tangible fixed assets22/27--€0.04m€0.03m▼ 23.1%
Furniture and vehicles24--€0.04m€0.03m▼ 23.1%
Financial fixed assets28€0.8m€0.8m€0.8m€0.8m=
Current assets29/58€0.02m€0.1m€0.09m€0.2m▲ 99.4%
Amounts receivable within one year40/41-€0.1m€0.07m€0.1m▲ 79.8%
Trade receivables40-€0.007m€0€0.01m-
Other amounts receivable41-€0.1m€0.07m€0.1m▲ 62.5%
Cash at bank and in hand54/58€0.02m€0.01m€0.01m€0.04m▲ 284%
Deferred charges and accrued income490/1€54€33€0.003m€0.001m▼ 80.8%
Equity and liabilities
Total equity and liabilities10/49€0.8m€1.0m€1.0m€1.1m▲ 8.1%
Equity10/15€0.01m€0.08m€0.1m€0.2m▲ 80.3%
Contributions10/11€0.001m€0.001m€0.001m€0.001m=
Reserves13€0.01m€0.08m€0.1m€0.2m▲ 80.9%
Distributable reserves133€0.01m€0.08m€0.1m€0.2m▲ 80.9%
Amounts payable17/49€0.8m€0.9m€0.8m€0.8m▼ 3.3%
Amounts payable after more than one year17€0.7m€0.8m€0.8m€0.7m▼ 6.8%
Financial debts170/4€0.7m€0.8m€0.8m€0.7m▼ 6.8%
Amounts payable within one year42/48€0.1m€0.1m€0.08m€0.1m▲ 18.4%
Current portion of amounts payable after more than one year42€0.04m€0.04m€0.05m€0.05m=
Trade debts44€0.001m€0.001m€0--
Suppliers440/4€0.001m€0.001m€0--
Taxes, remuneration and social security45€0.006m€0.02m€0.02m€0.05m▲ 167%
Taxes450/3€0.006m€0.01m€0.02m€0.05m▲ 180%
Remuneration and social security454/9-€0.001m€0.001m€0.001m=
Other amounts payable47/48€0.1m€0.06m€0.01m€284▼ 98.1%
Accrued charges and deferred income492/3-€0.004m€0.005m€0.01m▲ 144%
Line2022202320242025Change
Profit (loss) for the period9904€12,257€66,188€54,029€107,225▲ 98.5%
+ Depreciation and write-downs630€788€0€8,615€9,702▲ 12.6%
Operating cash flow (approximation)€13,045€66,188€62,643€116,927▲ 86.7%
Investment in fixed assets (approximation)--€55,588-€48,314-€602▲ 98.8%
Change in cash--€14,129€389€31,130▲ 7,904%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (4)
Financial year Type Filed Reference
31-12-2025 abbreviated format 11-07-2026 2026-00291413
31-12-2024 abbreviated format 11-07-2025 2025-00261336
31-12-2023 abbreviated format 17-07-2024 2024-00258794
31-12-2022 abbreviated format 24-07-2023 2023-00262487

Similar companies · same sector, comparable size

Of the 5,207 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,875. 3,540 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2022 · 1 entry · €90 awarded · €90 paid
Schemes
1 entry · €90 · €90 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 3 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

Group and network

Holdings and subsidiaries

2 holdings

Holdings 2

Source for every holding own accounts 2025

  • Equity €64,300Result -€5,604
    50%
  • Equity €477,087Result €98,632
    50%

According to the 2025 annual accounts of geroFarma and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.

Connections & network

No directors read yet: 0 of 3 Gazette acts processed.

History

GeroFarma was incorporated on 2 October 2021 as a private limited company.1 Total assets rose from €814,764 in 2022 to €1.1m in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2022 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
11-07
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial Highest result from 2022 to 2025net €107,225 ▲98.5%
Operating result €173,980, net result €107,225, both a record.
31-12
Financial Equity above €200,000equity €240,699 ▲80.3%
A profit in every financial year since 2022 builds equity to €240,699.
11-07
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
2024
31-12
Financial Equity above €100,000equity €133,474 ▲68%
A profit in every financial year since 2022 builds equity to €133,474.
17-07
NBB filing Annual accounts filed
financial year 2023 · abbreviated format
2023
31-12
Financial Liquidity times 6current ratio 1.01
Current ratio from 0.17 to 1.01; short-term debt falls from €147,756 to €117,179.
24-07
NBB filing Annual accounts filed
financial year 2022 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts

We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded02-10-2021
Financial year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0774941908
Also 9925:BE0774941908
Registered 31-10-2023

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 21 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Kortrijk · 1 establishment unit since 2021
registered office establishment The establishment unit on the map
Ground area
384 m²
Building footprint
165 m²
Building volume
894 m³
Parcel 34016C0761/00S004, Flanders · tallest building 10.2 m. Linked by address, not a title deed.
1 establishment unit
geroFarma
Albrecht Rodenbachlaan(Heu) 82, 8501 KortrijkRetail sale of pharmaceutical products
since 2021unit no. 2.322.378.948
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
34016C0761/00S004 Flanders 384 m² 1 · 165 m² 10.2 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.